Get started
RAMM PHARMA CORP.RR

RAMM PHARMA CORP.

0.015CADD
+0.005+50.00%
At close at Jan 31, 08:05 GMT
CAD
No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Seasonals

RAMM fundamentals

Key facts

Market capitalization‪2.39 M‬CAD
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)−0.14CAD
Founded1988
Employees (FY)—
CEOJackie Peter Burnett
Websitewearerammpharma.com
About

RAMM Pharma Corp. engages in the field of cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. It offers Epifractan and CannabiPiel. The company was founded on 26th October, 1988 and is headquartered in Toronto, Canada.

Ownership
‪‪119.39 M‬‬
Free Float shares
‪‪86.84 M‬‬ (72.73%)
Closely held shares
‪‪32.55 M‬‬ (27.27%)
Free Float shares
‪‪86.84 M‬‬ (72.73%)
Closely held shares
‪‪32.55 M‬‬ (27.27%)
Capital structure
Market cap
‪‪2.39 M‬‬
Debt
‪‪188.31 K‬‬
Cash & equivalents
‪‪814.04 K‬‬
Enterprise value
‪‪1.76 M‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪2.39 M‬‬
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
0.27x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
0.27x
Valuation ratios
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪0.40‬
‪0.80‬
‪1.20‬
‪1.60‬
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−1,280.00%‬
‪−980.00%‬
‪−680.00%‬
‪−380.00%‬
‪−80.00%‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−12.00 M‬‬
‪‪−8.00 M‬‬
‪‪−4.00 M‬‬
‪0.00‬
‪‪4.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−12.00 M‬‬
‪‪−8.00 M‬‬
‪‪−4.00 M‬‬
‪0.00‬
‪‪4.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−12.00 M‬‬
‪‪−8.00 M‬‬
‪‪−4.00 M‬‬
‪0.00‬
‪‪4.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Medical Devices and Consumables
Pharmaceutical Formulations
Services
Other
Cosmetics Products
By country
Period: 2024
Uruguay
Poland
Italy

Dividends

Dividend yield, history and sustainability

RAMM does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−2.00 M‬‬
‪0.00‬
‪‪2.00 M‬‬
‪‪4.00 M‬‬
‪‪6.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪3.00 M‬‬
‪‪6.00 M‬‬
‪‪9.00 M‬‬
‪‪12.00 M‬‬
Assets
Liabilities